Changing roles of eosinophils in health and disease

Annals of Allergy, Asthma and Immunology

Volumn 113, Issue 1, 2014, Pages 3-8

  Furuta, Glenn T ^a,b,c   Atkins, F Dan ^a,c   Lee, Nancy A ^d   Lee, James J ^d  

^a CHILDREN S HOSPITAL COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c University of Colorado Denver and Children s Hospital Colorado   (United States)

^d MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENRALIZUMAB; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 5 ANTIBODY; INTERLEUKIN 5 RECEPTOR; MAJOR BASIC PROTEIN; MEPOLIZUMAB; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; PLACEBO; RESLIZUMAB;

ALLERGIC ASTHMA; ALLERGIC DISEASE; ANTIINFLAMMATORY ACTIVITY; ASTHMA; ATOPIC DERMATITIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; EFFECTOR CELL; EOSINOPHIL; EOSINOPHIL COUNT; EOSINOPHILIA; EOSINOPHILIC GASTROINTESTINAL DISORDER; HOST RESISTANCE; HUMAN; HYPEREOSINOPHILIC SYNDROME; IMMUNE RESPONSE; IMMUNOMODULATION; INFLAMMATION; LEUKOCYTE FUNCTION; LEUKOCYTE MIGRATION; MOLECULARLY TARGETED THERAPY; MOUSE MODEL; MUCOSAL EOSINOPHILIA; NONHUMAN; PARASITE IMMUNITY; PHASE 1 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SPUTUM EOSINOPHILIA; TISSUE REPAIR; TREATMENT DURATION;

ANIMALS; ANTI-ALLERGIC AGENTS; ASTHMA; CELL MOVEMENT; DERMATITIS, ATOPIC; ENTERITIS; EOSINOPHILIA; EOSINOPHILS; GASTRITIS; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; HYPEREOSINOPHILIC SYNDROME; INTERLEUKIN-5; LEUKOCYTE COUNT; RECEPTORS, INTERLEUKIN-5;

EID: 84903145932     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2014.04.002     Document Type: Article

References (79)

1. J.J. Lee, and H.F. Rosenberg Eosinophils in Health and Disease 2012 Academic Press/Elsevier Waltham, MA
2. P. Erlich Ueber die Specifischen granulationen des Blutes Arch Anant Physiol 3 1879 571 579
3. G.J. Gleich Historical overview and perspective on the role of the eosinophil in health and disease J.J. Lee, H.F. Rosenberg, Eosinophils in Health and Disease 2012 Academic Press/Elsevier Waltham, MA 1 11
4. D. Dombrowicz, and M. Capron Eosinophils, allergy and parasites Curr Opin Immunol 13 2001 716 720 (Pubitemid 33000167)
5. H.L. Huber, and K.K. Koessler The pathology of bronchial asthma Arch Intern Med 30 1922 689 760
6. K.F. Austen Homeostasis of effector systems which can also be recruited for immunologic reactions [review] J Immunol 121 1978 793 805
7. S.R. Durham, C.F. Craddock, W.O. Cookson, and M.K. Benson Increases in airway responsiveness to histamine precede allergen-induced late asthmatic responses J Allergy Clin Immunol 82 1988 764 770 (Pubitemid 19003096)
8. S.J. Ackerman, D.A. Loegering, and P. Venge et al. Distinctive cationic proteins of the human eosinophil granule: major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin J Immunol 131 1983 2977 2982 (Pubitemid 14207333)
9. C.G. Peterson, and P. Venge Purification and characterization of a new cationic protein - eosinophil protein-X (EPX) - from granules of human eosinophils Immunology 50 1983 19 26 (Pubitemid 13039853)
10. M.G. Carlson, C.G. Peterson, and P. Venge Human eosinophil peroxidase: purification and characterization J Immunol 134 1985 1875 1879 (Pubitemid 15128954)
11. J.D. Young, C.G. Peterson, P. Venge, and Z.A. Cohn Mechanism of membrane damage mediated by human eosinophil cationic protein Nature 321 1986 613 616 (Pubitemid 16042213)
12. R. Hallgren, T. Samuelsson, P. Venge, and J. Modig Eosinophil activation in the lung is related to lung damage in adult respiratory distress syndrome Am Rev Respir Dis 135 1987 639 642 (Pubitemid 17041598)
13. P. Venge, R. Dahl, K. Fredens, and C.G. Peterson Epithelial injury by human eosinophils Am Rev Respir Dis 138 1988 S54 S57
14. G.J. Gleich, E. Frigas, D.A. Loegering, D.L. Wassom, and D. Steinmuller Cytotoxic properties of the eosinophil major basic protein J Immunol 123 1979 2925 2927 (Pubitemid 10202545)
15. J.H. Butterfield, D.E. Maddox, and G.J. Gleich The eosinophil leukocyte: maturation and function Clin Immunol Rev 2 1983 187 306
16. K.J. Hamann, R.L. Barker, D.A. Loegering, and G.J. Gleich Comparative toxicity of purified human eosinophil granule proteins for newborn larvae of Trichinella spiralis J Parasitol 73 1987 523 529
17. H.A. Molina, F. Kierszenbaum, K.J. Hamann, and G.J. Gleich Toxic effects produced or mediated by human eosinophil granule components on Trypanosoma cruzi Am J Trop Med Hyg 38 1988 327 334 (Pubitemid 18086114)
18. G.H. Ayars, L.C. Altman, and M.M. McManus et al. Injurious effect of the eosinophil peroxide-hydrogen peroxide-halide system and major basic protein on human nasal epithelium in vitro Am Rev Respir Dis 140 1989 125 131 (Pubitemid 19177092)
19. K. Hisamatsu, T. Ganbo, and T. Nakazawa et al. Cytotoxicity of human eosinophil granule major basic protein to human nasal sinus mucosa in vitro J Allergy Clin Immunol 86 1990 52 63 (Pubitemid 20226844)
20. M. Capron, H. Bazin, M. Joseph, and A. Capron Evidence for IgE-dependent cytotoxicity by rat eosinophils J Immunol 126 1981 1764 1768 (Pubitemid 11120954)
21. L. Prin, M. Capron, A.B. Tonnel, O. Bletry, and A. Capron Heterogeneity of human peripheral blood eosinophils: variability in cell density and cytotoxic ability in relation to the level and the origin of hypereosinophilia Int Arch Allergy Appl Immunol 72 1983 336 346 (Pubitemid 14246597)
22. E. Frigas, S. Motojima, and G.J. Gleich The eosinophilic injury to the mucosa of the airways in the pathogenesis of bronchial asthma [review] Eur Respir J Suppl 13 1991 123s 135s
23. S.J. Ackerman, G.J. Gleich, D.A. Loegering, B.A. Richardson, and A.E. Butterworth Comparative toxicity of purified human eosinophil granule cationic proteins for schistosomula of Schistosoma mansoni Am J Trop Med Hyg 34 1985 735 745 (Pubitemid 16237019)
24. K.J. Hamann, G.J. Gleich, and J.L. Checkel et al. In vitro killing of microfilariae of Brugia pahangi and Brugia malayi by eosinophil granule proteins J Immunol 144 1990 3166 3173 (Pubitemid 20149496)
25. W.V. Filley, K.E. Holley, G.M. Kephart, and G.J. Gleich Identification by immunofluorescence of eosinophil granule major basic protein in lung tissues of patients with bronchial asthma Lancet 2 1982 11 16 (Pubitemid 12124112)
26. G.J. Gleich, S. Motojima, and E. Frigas et al. The eosinophilic leukocyte and the pathology of fatal bronchial asthma: evidence for pathologic heterogeneity J Allergy Clin Immunol 80 1987 412 415 (Pubitemid 17135992)
27. P.S. Foster, S.P. Hogan, A.J. Ramsay, K.I. Matthaei, and I.G. Young Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model [see comments] J Exp Med 183 1996 195 201 (Pubitemid 26028759)
28. S.P. Hogan, K.I. Matthaei, and J.M. Young et al. A novel T cell-regulated mechanism modulating allergen-induced airways hyperreactivity in BALB/c mice independently of IL-4 and IL-5 J Immunol 161 1998 1501 1509 (Pubitemid 28380583)
29. E. Hamelmann, A. Oshiba, and J. Loader et al. Antiinterleukin-5 antibody prevents airway hyperresponsiveness in a murine model of airway sensitization Am J Respir Crit Care Med 155 1997 819 825 (Pubitemid 27133388)
30. P. Nair, M.M. Pizzichini, and M. Kjarsgaard et al. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia N Engl J Med 360 2009 985 993
31. P. Haldar, C.E. Brightling, and B. Hargadon et al. Mepolizumab and exacerbations of refractory eosinophilic asthma N Engl J Med 360 2009 973 984
32. A. Ghazi, A. Trikha, and W.J. Calhoun Benralizumab - a humanized mAb to IL-5Ralpha with enhanced antibody-dependent cell-mediated cytotoxicity - a novel approach for the treatment of asthma Expert Opin Biol Ther 12 2012 113 118
33. S.E. Wenzel Eosinophils in asthma - closing the loop or opening the door? N Engl J Med 360 2009 1026 1028
34. W.J. Calhoun, B.T. Ameredes, and T.S. King et al. Comparison of physician-, biomarker-, and symptom-based strategies for adjustment of inhaled corticosteroid therapy in adults with asthma: the BASALT randomized controlled trial JAMA 308 2012 987 997
35. K.L. Denzler, S.C. Farmer, and J.R. Crosby et al. Eosinophil major basic protein-1 does not contribute to allergen-induced airway pathologies in mouse models of asthma J Immunol 165 2000 5509 5517
36. K.L. Denzler, M.T. Borchers, and J.R. Crosby et al. Extensive eosinophil degranulation and peroxidase-mediated oxidation of airway proteins do not occur in a mouse ovalbumin-challenge model of pulmonary inflammation J Immunol 167 2001 1672 1682 (Pubitemid 32703170)
37. J.J. Lee, D. Dimina, and M.P. Macias et al. Defining a link with asthma in mice congenitally deficient in eosinophils Science 305 2004 1773 1776 (Pubitemid 39249644)
38. A.A. Humbles, C.M. Lloyd, and S.J. McMillan et al. A critical role for eosinophils in allergic airways remodeling Science 305 2004 1776 1779 (Pubitemid 39249645)
39. A.D. Doyle, E.A. Jacobsen, and S.I. Ochkur et al. Expression of the secondary granule proteins major basic protein (MBP)-1 and eosinophil peroxidase (EPX) is required for eosinophilopoiesis in mice Blood 122 2013 781 790
40. E.A. Jacobsen, W.E. LeSuer, and L. Willetts et al. Eosinophil activities modulate the immune/inflammatory character of allergic respiratory responses in mice Allergy 69 2014 315 327
41. S. Specht, M. Saeftel, and M. Arndt et al. Lack of eosinophil peroxidase or major basic protein impairs defense against murine filarial infection Infect Immun 74 2006 5236 5243 (Pubitemid 44300442)
42. A.E. O'Connell, J.A. Hess, and G.A. Santiago et al. Major basic protein from eosinophils and myeloperoxidase from neutrophils are required for protective immunity to Strongyloides stercoralis in mice Infect Immun 79 2011 2770 2778
43. J.M. Swartz, K.D. Dyer, and A.W. Cheever et al. Schistosoma mansoni infection in eosinophil lineage-ablated mice Blood 108 2006 2420 2427 (Pubitemid 44497528)
44. V. Fabre, D.P. Beiting, and S.K. Bliss et al. Eosinophil deficiency compromises parasite survival in chronic nematode infection J Immunol 182 2009 1577 1583
45. N.G. Gebreselassie, A.R. Moorhead, and V. Fabre et al. Eosinophils preserve parasitic nematode larvae by regulating local immunity J Immunol 188 2012 417 425
46. D. Voehringer, K. Shinkai, and R.M. Locksley Type 2 immunity reflects orchestrated recruitment of cells committed to IL-4 production Immunity 20 2004 267 277 (Pubitemid 38388229)
47. J.P. Justice, M.T. Borchers, and J.J. Lee et al. Ragweed-induced expression of GATA-3, IL-4, and IL-5 by eosinophils in the lungs of allergic C57BL/6 mice Am J Physiol Lung Cell Mol Physiol 282 2002 L302 L309
48. E.A. Jacobsen, S.I. Ochkur, and R.S. Pero et al. Allergic pulmonary inflammation in mice is dependent on eosinophil-induced recruitment of effector T cells J Exp Med 205 2008 699 710 (Pubitemid 351439314)
49. E.R. Walsh, N. Sahu, and J. Kearley et al. Strain-specific requirement for eosinophils in the recruitment of T cells to the lung during the development of allergic asthma J Exp Med 205 2008 1285 1292 (Pubitemid 351831486)
50. E.A. Jacobsen, K.R. Zellner, D. Colbert, N.A. Lee, and J.J. Lee Eosinophils regulate dendritic cells and Th2 pulmonary immune responses following allergen provocation J Immunol 187 2011 6059 6068
51. D. Wu, A.B. Molofsky, and H.E. Liang et al. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis Science 332 2011 243 247
52. A.B. Molofsky, J.C. Nussbaum, and H.E. Liang et al. Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages J Exp Med 210 2013 535 549
53. Y.P. Goh, N.C. Henderson, and J.E. Heredia et al. Eosinophils secrete IL-4 to facilitate liver regeneration Proc Natl Acad Sci U S A 110 2013 9914 9919
54. J.E. Heredia, L. Mukundan, and F.M. Chen et al. Type 2 innate signals stimulate fibro/adipogenic progenitors to facilitate muscle regeneration Cell 153 2013 376 388
55. H. Zhang, and A.S. Verkman Eosinophil pathogenicity mechanisms and therapeutics in neuromyelitis optica J Clin Invest 123 2013 2306 2316
56. J.J. Lee, E.A. Jacobsen, M.P. McGarry, R.P. Schleimer, and N.A. Lee Eosinophils in health and disease: the LIAR hypothesis Clin Exp Allergy 40 2010 563 575
57. S.H. Wedes, W. Wu, and S.A. Comhair et al. Urinary bromotyrosine measures asthma control and predicts asthma exacerbations in children J Pediatr 159 2011 248 255.e1
58. D.S. Robinson, B. Assoufi, S.R. Durham, and A.B. Kay Eosinophil cationic protein (ECP) and eosinophil protein X (EPX) concentrations in serum and bronchial lavage fluid in asthma. Effect of prednisolone treatment Clin Exp Allergy 25 1995 1118 1127
59. I. Stelmach, P. Majak, and T. Grzelewski et al. The ECP/Eo count ratio in children with asthma J Asthma 41 2004 539 546 (Pubitemid 39202447)
60. E. Hui, and R.D. Vale In vitro membrane reconstitution of the T-cell receptor proximal signaling network Nat Struct Mol Biol 21 2014 133 142
61. G.T. Furuta, A.F. Kagalwalla, and J.J. Lee et al. The oesophageal string test: a novel, minimally invasive method measures mucosal inflammation in eosinophilic oesophagitis and pollen Gut 62 2013 1395 1405
62. K.D. Stone, and C. Prussin Immunomodulatory therapy of eosinophil-associated gastrointestinal diseases Clin Exp Allergy 38 2008 1858 1865
63. M.E. Wechsler, P.C. Fulkerson, and B.S. Bochner et al. Novel targeted therapies for eosinophilic disorders J Allergy Clin Immunol 130 2012 563 571
64. J.P. Abonia, and P.E. Putnam Mepolizumab in eosinophilic disorders Expert Rev Clin Immunol 7 2011 411 417
65. G.M. Walsh Profile of reslizumab in eosinophilic disease and its potential in the treatment of poorly controlled eosinophilic asthma Biologics 7 2013 7 11
66. G.M. Walsh Mepolizumab and eosinophil-mediated disease Curr Med Chem 16 2009 4774 4778
67. M.J. Leckie, A. ten Brinke, and J. Khan et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response Lancet 356 2000 2144 2148
68. P. Flood-Page, A. Menzies-Gow, and S. Phipps et al. Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics J Clin Invest 112 2003 1029 1036 (Pubitemid 38056318)
69. M. Castro, S. Mathur, and F. Hargreave et al. Reslizumab for poorly controlled, eosinophilic asthma Am J Respir Crit Care Med 184 2011 1125 1132
70. M. Laviolette, D.L. Gossage, and G. Gauvreau et al. Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia J Allergy Clin Immunol 132 2013 1086 1096.e5
71. A. Menzies-Gow, P. Flood-Page, and R. Sehmi et al. Anti-IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics J Allergy Clin Immunol 111 2003 714 719 (Pubitemid 36470238)
72. M.E. Rothenberg, A.D. Klion, and F.E. Roufosse et al. Treatment of patients with the hypereosinophilic syndrome with mepolizumab N Engl J Med 358 2008 1215 1228 (Pubitemid 351439223)
73. M.L. Stein, M.H. Collins, and J.M. Villanueva et al. Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis J Allergy Clin Immunol 118 2006 1312 1319 (Pubitemid 44872890)
74. A. Straumann, S. Conus, and P. Grzonka et al. Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial Gut 59 2010 21 30
75. A.H. Assa'ad, S.K. Gupta, and M.H. Collins et al. An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis Gastroenterology 141 2011 1593 1604
76. J.M. Spergel, M.E. Rothenberg, and M.H. Collins et al. Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial J Allergy Clin Immunol 129 2012 456 463 463.e1-3
77. I.M. Otani, A.A. Anilkumar, and R.O. Newbury et al. Anti-IL-5 therapy reduces mast cell and IL-9 cell numbers in pediatric patients with eosinophilic esophagitis J Allergy Clin Immunol 131 2013 1576 1582
78. S. Phipps, P. Flood-Page, A. Menzies-Gow, Y.E. Ong, and A.B. Kay Intravenous anti-IL-5 monoclonal antibody reduces eosinophils and tenascin deposition in allergen-challenged human atopic skin J Invest Dermatol 122 2004 1406 1412 (Pubitemid 38757222)
79. J.M. Oldhoff, U. Darsow, and T. Werfel et al. Anti-IL-5 recombinant humanized monoclonal antibody (mepolizumab) for the treatment of atopic dermatitis Allergy 60 2005 693 696 (Pubitemid 40562479)